89 FR 104 pg. 46420 - Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC; Correction
Type: NOTICEVolume: 89Number: 104Page: 46420
Page: 46420Docket number: [Docket No. DEA-1357]
FR document: [FR Doc. 2024-11746 Filed 5-28-24; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1357]
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC; Correction
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice; correction.
SUMMARY:
The Drug Enforcement Administration (DEA) published a document in the Federal Register on May 6, 2024, concerning an application for a Bulk Manufacturer of Controlled Substances. A request was made for the removal of the following information: "The company plans to bulk manufacture the listed controlled substances for the purpose of producing material for clinical trials." Please correct notice to read as follows as stated under Supplementary Information.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register on May 6, 2024, in FR Doc. 2024-09805, (89 FR 37260), 37260-37261 (2 pages). The purpose is to manufacture bulk noroxymorphone as an intermediate product to be sold to a customer who will indicate a Contract Manufacturer Organization (CMO), which the material will be shipped to, to be converted to a non-controlled substance. Oxymorphone (9652) will be used as a starting material to be converted to Noroxymorphone (9668).
No other activities for these drug codes are authorized for this registration.
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Oxymorphone | 9652 | II |
| Noroxymorphone | 9668 | II |
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-11746 Filed 5-28-24; 8:45 am]
BILLING CODE 4410-09-P